Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia

Publication Name : Cancer Treatment and Research Communications, 100979, 2025

Citation : 1

Date : 2025

Publication URL

https://scholar.google.com/scholar?q=+intitle:"Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia"

Authors

NOVITA ANDAYANI

Sp-1 - Pulmonologi dan Kedokteran Respirasi

Files